A SIMPLE EPIGENETIC SIGNATURE DEFINES TWO BIOLOGIC GROUPS OF MANTLE CELL LYMPHOMA

EHA Library, Marco Bühler, 325616

EZH2 INHIBITOR TAZEMETOSTAT DEMONSTRATES ACTIVITY IN PRECLINICAL MODELS OF BRUTON’S TYROSINE KINASE INHIBITOR-RESISTANT MANTLE CELL LYMPHOMA

EHA Library, Alejandra Raimondi, 325617

NEXT GENERATION SEQUENCING PROVIDES NOVEL MOLECULAR MARKERS FOR MINIMAL RESIDUAL DISEASE MONITORING IN FOLLICULAR LYMPHOMA: BIOLOGICAL RESULTS FROM FONDAZIONE ITALIANA LINFOMI (FIL) FOLL12 TRIAL

EHA Library, Simone Ferrero, 325618

PRMT5 INHIBITION RESTARTS A PRO-APOPTOTIC PROGRAM AND CREATES VULNERABILITY TO COMBINATION TREATMENT WITH BCL-2 INHIBITOR VENETOCLAX IN MANTLE CELL LYMPHOMA

EHA Library, Fiona Brown, 325619

TARGETING GLYCOPROTEIN PTGDS INHIBITS THE PROGRESSION OF DIFFUSE LARGE B-CELL LYMPHOMA THROUGH MYH9-WNT-Β-CATENIN/STAT3 AXIS

EHA Library, Shunfeng Hu, 325620

A CIRCULAR RNA EXPRESSION SIGNATURE PREDICTS DISMAL OUTCOME IN MANTLE CELL LYMPHOMA: A STUDY OF YOUNGER PATIENTS FROM THE NORDIC MCL2 AND MCL3 CLINICAL TRIALS

EHA Library, Mette Dahl, 325621

IDENTIFICATION OF M6A METHYLTRANSFERASE KIAA1429 AS A POTENTIAL TARGET IN DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, Xiaomin Chen, 325622

PLK4 INHIBITION BY CFI-400945 ENHANCES DOXORUBICIN SENSITIVITY IN DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, Yi Zhao, 325623

SUPPRESSION OF NUSAP1 INHIBITS CELL PROLIFERATION IN DIFFUSE LARGE B-CELL LYMPHOMA THROUGH DNA DAMAGE REPAIR PATHWAY

EHA Library, Yang Han, 325624

TIGIT EXPRESSION AND ITS SCORING SYSTEM IN CLASSIC HODGKIN LYMPHOMA: A NOVEL THERAPEUTIC TARGET?

EHA Library, Ombretta Annibali, 325625

SERUM EXOSOMAL MICRORNAS AS NOVEL NON-INVASIVE BIOMARKERS FOR DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, Jiarui Liu, 325626

DISCOVERY AND PRECLINICAL PROPERTIES OF JNJ-64264681, A POTENT AND SELECTIVE COVALENT BTK INHIBITOR FOR THE TREATMENT OF B CELL MALIGNANCIES

EHA Library, Ulrike Philippar, 325627

ANALYSIS OF EZH2 MUTATIONS IN SOLID AND LIQUID BIOPSY AND ITS ROLE AS PREDICTIVE MARKER FOR CHEMOTHERAPY IN PATIENTS WITH FOLLICULAR LYMPHOMA

EHA Library, Mariana Bastos Oreiro, 325628

MELPHALAN FLUFENAMIDE IS A HIGHLY POTENT ANTI-NEOPLASTIC AGENT IN HIGH RISK DLBCL MODELS

EHA Library, Konstantin Byrgazov, 325629

GENOMEWIDE COPY NUMBER ANALYSIS OF GRADE 1-3A, 3B, AND COMPOSITE FOLLICULAR LYMPHOMA

EHA Library, Pablo Mozas, 325630

T-CELL SUBSET COMPOSITION AND FUNCTIONALITY IN PATIENTS WITH WALDENSTRÖM’S MACROGLOBULINEMIA.

EHA Library, Karima Amaador, 325631

BERBERINE EXERTS IMMUNOREGULATING FUNCTION IN DIFFUSE LARGE B-CELL LYMPHOMA VIA DOWNREGULATING CD47 EXPRESSION

EHA Library, Shuai Ren, 325632

ABERRANT EPIGENETIC REGULATION THROUGH METABOLIC REPROGRAMMING IN ATL LEUKEMOGENESIS

EHA Library, Tatsuro Watanabe, 325633

XENOGRAFT MODELLING OF DRIVING MOLECULAR EVENTS IN BURKITT LYMPHOMA

EHA Library, Simon Bomken, 325634

CHN1 IS A NOVEL PROGNOSTIC MARKER FOR DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, Jie Sun, 325635

CCL2-CCR2 AXIS SIGNALING PROMOTES DIFFUSE LARGE B-CELL LYMPHOMA CELL SURVIVAL AND INVASION

EHA Library, Yan-Li Li, 325636

LENALIDOMIDE-INDUCED EFFECTS ON CELL SURFACE EXPRESSION OF CD19 AND CD20 IN DLBCL CELL LINES AND FUNCTIONAL IMPACT ON ANTIBODY-MEDIATED CYTOTOXICITY

EHA Library, Maria Patra-Kneuer, 325637

LOW PERCENTAGE OF T-LYMPHOCYTES IN FOLLICULAR LYMPHOMA LYMPH NODE BIOPSIES, MEASURED BY FLOW CYTOMETRY, IS ASSOCIATED WITH INFERIOR PROGRESSION FREE SURVIVAL.

EHA Library, Laura Korin, 325638

PROGNOSTIC ROLE OF CD30 FROM A RETROSPECTIVE REVIEW OF 295 PATIENTS WITH ANGIOIMMUNOBLASTIC T CELL LYMPHOMA

EHA Library, Julia Parrish, 325639

EXPRESSION AND CLINICAL SIGNIFICANCE OF STING IN T- AND NK-CELL NON HODGKIN LYMPHOMAS

EHA Library, Ioanna Xagoraris, 325640

SERUM MIR-22 AS NOVEL NON-INVASIVE PREDICTOR OF CLINICAL OUTCOME AND RESPONSE TO THERAPY IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, Francesco Marchesi, 325641

TUMOR MICROSATELLITE ANALYSIS IN B-CELL LYMPHOMAS

EHA Library, Sychevskaya Kseniia, 325642

RELIABLE DETECTION OF T-CELL CLONALITY BY FLOW CYTOMETRY IN MATURE T-CELL NEOPLASMS USING TCR Β CONSTANT REGION 1 (TRBC1): A COMPARISON WITH PCR BASED CLONALITY TESTING.

EHA Library, Deirdre Waldron, 325643

DIFFERENT ABDOMINAL FAT COMPARTMENTS DIFFERENTLY REFLECT ON PROGNOSIS IN CLASSICAL HODGKIN LYMPHOMA PATIENTS

EHA Library, Marko Lucijanic, 325644

TRITON X-114 AND AMINE-BASED WASH STRATEGY REDUCES LPS TO FDA-LIMIT AND ACHIEVES PURER, MORE POTENT RECOMBINANT IMMUNOTOXIN.

EHA Library, Rebekka George, 325645

IMPLICATIONS OF THE SPLICEOSOME MUTATION U2AF1 FOR THE EXPRESSION OF CIRCULAR RNA

EHA Library, Eileen Wedge, 325646

MYELODYSPLASTIC SYNDROME IN YOUNG ADULT WITHOUT PREVIOUS ORGANIC DISFUNCTION: PREDOMINANCE OF GERMLINE VARIANTS IN GENES OF DNA REPAIR PATHWAY AND THEIR CLINICAL IMPACT

EHA Library, Tzu-Hua Chen Liang, 325647

MOLECULAR AND CYTOGENETIC CHARACTERIZATION OF MYELODYSPLASTIC SYNDROMES IN CELL-FREE DNA

EHA Library, Nieves Garcia-Gisbert, 325648

ALL-TRANS RETINOIC ACID ENHANCES THE CYTOTOXIC EFFECT OF DECITABINE ON MYELODYSPLASTIC SYNDROMES VIA ACTIVATING RARΑ-NRF2 COMPLEX

EHA Library, Lu Wang, 325649

LESS CAN BE MORE – GENDER-RELATED MUTATIONAL LANDSCAPE AND OUTCOME IN MYELODYSPLASTIC SYNDROME

EHA Library, Manja Meggendorfer, 325650

COHESIN MUTATIONS ARE ASSOCIATED WITH A POOR PROGNOSIS PHENOTYPE AND A WORSE CLINICAL OUTCOME IN LOW-RISK MYELODYSPLASTIC SYNDROMES PATIENTS

EHA Library, Marta Martín Izquierdo, 325651

SINGLE-CELL RNA SEQUENCING TO EXPLORE THE ABNORMAL DIFFERENTIATION OF HEMATOPOIETIC STEM AND PROGENITOR CELLS IN MYELODYSPLASTIC SYNDROMES AND ACUTE MYELOID LEUKEMIA

EHA Library, Yumei Liu, 325652

LNCRNA PCSK1N-202 PROMOTES CD34+CELL PROLIFERATION VIA PIM2/HIF-1Α IN MYELODYSPLASTIC SYNDROMES

EHA Library, Zhaoyun Liu, 325653

CLONAL HEMATOPOIESIS IS COMMON IN HIP ARTHROPLASTY PATIENTS AND ASSOCIATES WITH AUTOIMMUNE DISEASE AND LOWER HEMOGLOBIN LEVELS

EHA Library, Judith S. Hecker, 325654

THE CAR VIRUS RECEPTOR MEDIATES MATURATION AND MIGRATION IN ERYTHROID PRECURSOR CELLS AND IS DOWNREGULATED IN MDS

EHA Library, Karin Bauer, 325655

UNCLASSIFIABLE MYELODYSPLASTIC SYNDROME DEFINED BY A CYTOGENETIC ABNORMALITY: A REAL-LIFE STUDY.

EHA Library, Victor-Emmanuel Brett, 325656

USING TISSUE MICROARRAY TO DETECT INFLAMMASOME SIGNALING COMPONENTS THAT CONTRIBUTE TO THE PATHOGENESIS OF MYELODYSPLASTIC SYNDROME

EHA Library, Tony Kurian, 325657

PIM INHIBITORS INDUCE THE FERROPTOSIS VIA HIF1A/GPX4 PATHWAY IN HEMATOLOGICAL MALIGNANT CELLS

EHA Library, Rong Fu, 325658

BMSCS REGULATE THE FUNCTION OF NK CELL BY CD155/TIGIT/CD226 PATHWAY IN MDS PATIENTS

EHA Library, Zhaoyun Liu, 325659

PHARMACOLOGIC INHIBITORS OF CDK4/CDK6 EXERT ANTI-NEOPLASTIC EFFECTS ON CMML CELLS AND SYNERGIZE WITH THE MULTI-KINASE INHIBITOR PONATINIB IN NEOPLASTIC MONOCYTES

EHA Library, Max V. John, 325660

THE PIVOTAL ROLE OF WEE1 AND PARP-1 IN MYELODYSPLASTIC SYNDROME (MDS): A NEW STRATEGY FOR THE TARGETED THERAPY OF MDS

EHA Library, Seiichi Okabe, 325661

AZACITIDINE SEQUENCED WITH RIGOSERTIB DOWNREGULATES NEGATIVE REGULATORS OF HEMATOPOIESIS INCLUDING MULTIPLE MAPK PATHWAYS IMPACTING STEMNESS/DIFFERENTIATION OF MDS-L CELLS WITH CLINICAL IMPLICATIONS

EHA Library, Richa Rai, 325662

PHENOTYPIC AND GENETIC FEATURES OF MYELODYSPLASTIC SYNDROME (MDS) BONE MARROW (BM) DERIVED MESENCHYMAL STROMAL CELLS (MSC) FOR DISEASE PROGNOSIS AND THERAPY

EHA Library, Zhiyong Poon, 325663

PREVALENCE OF UBA1 MUTATIONS IN MDS/CMML PATIENTS WITH SYSTEMIC INFLAMMATORY AND AUTO-IMMUNE DISEASE

EHA Library, Lin-Pierre Zhao, 325664

MESENCHYMAL STROMAL CELLS AS A POTENTIAL THERAPEUTIC TOOL IN ENHANCING RESIDUAL HEALTHY HAEMATOPOIESIS IN LOW-RISK MDS PATIENTS

EHA Library, Tamara Jiménez, 325665

SIMPLE FLOW CYTOMETRY IMMUNOPHENOTYPING APPROACH PREDICTS THE DEVELOPMENT OF MYELOID NEOPLASMS IN PATIENTS WITH CCUS

EHA Library, Dragan Jevremovic, 325666

VENETOCLAX AND AZACITIDINE COMBINATION IN CHEMOTHERAPY INELIGIBLE PATIENTS WITH THERAPY-RELATED MYELOID NEOPLASMS, ANTECEDENT MYELODYSPLASTIC SYNDROMES OR MYELODYSPLASTIC/MYELOPROLIFERATIVE NEOPLASMS

EHA Library, Vinod A. Pullarkat, 325667

EFFICACY OF IMETELSTAT IS INDEPENDENT OF MOLECULAR SUBTYPES IN HEAVILY TRANSFUSED NON-DEL(5Q) LOWER RISK MDS (LR-MDS) RELAPSED/REFRACTORY (R/R) TO ERYTHROPOIESIS STIMULATING AGENTS (ESA)

EHA Library, Uwe Platzbecker, 325668

A MACHINE LEARNING APPROACH TO PREDICTING RISK OF MYELODYSPLASTIC SYNDROME

EHA Library, Ashwath Radhachandran, 325669

THERAPY-RELATED MDS; A WIDE DEFINITION THAT NEEDS NARROWING

EHA Library, Daniel Berggren, 325670

RESULTS OF A PHASE I/II CLINICAL TRIAL COMBINING GUADECITABINE WITH ATEZOLIZUMAB IN PATIENTS WITH RELAPSED OR REFRACTORY MYELODYSPLASTIC SYNDROME (MDS) OR CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML)

EHA Library, Casey L OConnell, 325671

ASXL1 MUTATIONS PREDICT A POOR RESPONSE TO DARBEPOETIN ALFA IN ANEMIC PATIENTS WITH LOW-RISK MDS: A MULTICENTER, PHASE II STUDY

EHA Library, Motoshi Ichikawa, 325672

BENEFIT OF CONTINUING LUSPATERCEPT THERAPY IN PATIENTS WITH LOWER-RISK MYELODYSPLASTIC SYNDROMES WHO DID NOT ACHIEVE RED BLOOD CELL TRANSFUSION INDEPENDENCE BY WEEK 25 IN THE MEDALIST STUDY

EHA Library, Ulrich Germing, 325673

PREDICTORS OF HYPOMETHYLATING AGENT DISCONTINUATION AMONG PATIENTS WITH HIGHER-RISK MYELODYSPLASTIC SYNDROMES

EHA Library, Amer M. Zeidan, 325674

UPDATED SAFETY AND EFFICACY OF VENETOCLAX IN COMBINATION WITH AZACITIDINE FOR THE TREATMENT OF PATIENTS WITH TREATMENT-NAÏVE HIGHER-RISK MYELODYSPLASTIC SYNDROMES: PHASE 1B RESULTS

EHA Library, Andrew Wei, 325675

SIMILAR SURVIVAL AND GENETIC FEATURES BETWEEN CLONAL CYTOPENIA OF UNDETERMINED SIGNIFICANCE AND LOWER-RISK MYELODYSPLASTIC SYNDROME

EHA Library, Eun-Ji Choi, 325676

CHARACTERISTICS AND OUTCOMES OF MYELODYSPLASTIC SYNDROMES (MDS) WITH ISOLATED THROMBOCYTOPENIA: A RETROSPECTIVE, NATIONAL, COHORT STUDY

EHA Library, Konstantinos Liapis, 325677

LUSPATERCEPT REDUCES RED BLOOD CELL TRANSFUSIONS IN PATIENTS WITH LOWER-RISK MYELODYSPLASTIC SYNDROMES REGARDLESS OF BASELINE TRANSFUSION BURDEN IN THE MEDALIST STUDY

EHA Library, Guillermo Garcia-Manero, 325678

FLOW-CYTOMETRIC ASSESSMENT OF BONE MARROW MICROENVIRONMENT IN LOW-RISK MYELODYSPLASTIC SYNDROMES

EHA Library, Juri Alessandro Giannotta, 325679

A CIBERSORTX-BASED IMMUNE-CELL SCORING SYSTEM COULD INDEPENDENTLY PREDICT PROGNOSIS OF MYELODYSPLASTIC SYNDROME PATIENTS

EHA Library, Yu-Hung Wang, 325680

VENETOCLAX COMBINED WITH AZACITIDINE IN THE TREATMENT OF RELAPSED/REFRACTORY HIGH-RISK MYELODYSPLASTIC SYNDROMES AND ACUTE MYELOID LEUKEMIA: A RETROSPECTIVE SINGLE-CENTER STUDY

EHA Library, Hongyan Tong, 325681

UPDATED OVERALL SURVIVAL OF ELTANEXOR FOR THE TREATMENT OF PATIENTS WITH HYPOMETHYLATING AGENT REFRACTORY MYELODYSPLASTIC SYNDROME

EHA Library, Sangmin Lee, 325682

EARLY DECREASE IN VARIANT ALLELE FREQUENCY IN PERIPHERAL BLOOD WITH DROPLET DIGITAL PCR IN MYELODYSPLASTIC SYNDROME (MDS) PATIENTS RESPONDING TO AZACITIDINE

EHA Library, Johanna Illman, 325683

COMPARISON OF DOSE MODIFICATION STRATEGIES TO ADDRESS EXPECTED HEMATOLOGIC TOXICITIES IN TREATMENT-NAÏVE HIGHER-RISK (HR) MDS PATIENTS TREATED WITH VENETOCLAX + AZACITIDINE

EHA Library, Uwe Platzbecker, 325684

PROGNOSTIC IMPACT OF BONE MARROW FIBROSIS IN PRIMARY MYELODYSPLASTIC SYNDROMES

EHA Library, Maria Florencia Russo, 325685

DOSE SELECTION OF PEVONEDISTAT + AZACITIDINE IN PATIENTS WITH HIGHER-RISK MYELODYSPLASTIC SYNDROMES/CHRONIC MYELOMONOCYTIC LEUKEMIA AND ACUTE MYELOID LEUKEMIA: A MODEL-BASED ANALYSIS

EHA Library, Xiaofei Zhou, 325686

CLINICAL FEATURES OF MYELOID NEOPLASMS WITH DDX41 MUTATION: A SYSTEMATIC REVIEW AND META-ANALYSIS

EHA Library, Ziqi Wan, 325687

QUANTIFYING THE HEALTHCARE RESOURCE USE AND CLINICAL OUTCOMES OF PATIENTS WITH MYELODYSPLASTIC SYNDROME WITH RINGED SIDEROBLASTS IN ENGLAND

EHA Library, James Farrell, 325688

HIGH TRANSFERRIN SATURATION PREDICTS INFERIOR CLINICAL OUTCOMES IN PATIENTS WITH MDS

EHA Library, Jennifer Teichman, 325689

CIRCULATING MICRORNA MIR-99B AND MIR-125A IN MYELODYSPLASTIC SYNDROME-NONINVASIVE DIAGNOSTIC AND PROGNOSTIC BIOMARKERS

EHA Library, Inga MANDAC ROGULJ, 325690

THE R-IPSS DOES NOT SEEM TO ACCURATELY PREDICT FATAL EVENTS IN MYELODYSPLASTIC SYNDROME PATIENTS WITH AUTOIMMUNE DISEASES

EHA Library, Jose Miguel Torregrosa-Díaz, 325691

IMPACT OF TRANSFORMATION TO ACUTE MYELOID LEUKEMIA (AML) ON OVERALL SURVIVAL (OS) AMONG PATIENTS (PTS) WITH HIGHER-RISK MYELODYSPLASTIC SYNDROMES (HR-MDS) IN THE UNITED STATES OF AMERICA (USA)

EHA Library, Vamsi Kota, 325692

CHANGES IN THE CONCENTRATION OF TUMOR NECROSIS FACTOR TNF- IN BLOOD SERUM AND THE LEVEL OF CD33+ SUBSTRATE CELLS IN THE BONE MARROW OF PATIENTS WITH MYELODYSPLASTIC SYNDROME.

EHA Library, Halyna Starodub, 325693

GENOMIC CORRELATES OF RESPONSE TO SELINEXOR IN MULTIPLE MYELOMA FROM THE BOSTON STUDY REVEAL A PREDICTIVE SIGNATURE

EHA Library, Paula Restrepo, 325694

DEVELOPMENT OF NEXT-GENERATION ANTITUMOR ANTIBODIES ARMED WITH BRIDGING-BITE TO ADVANCE ANTI-MYELOMA IMMUNOTHERAPY

EHA Library, Tatsuya Konishi, 325695

ISB 1342: A FIRST-IN-CLASS CD38 T CELL ENGAGER FOR THE TREATMENT OF RELAPSED REFRACTORY MULTIPLE MYELOMA

EHA Library, Mario Perro, 325696

A NOVEL ONCOLYTIC LENTIVIRAL VECTOR FOR THE TARGETED AND THERAPEUTIC IFNΒ- EXPRESSION IN MULTIPLE MYELOMA

EHA Library, Eleni Kalafati, 325697

LONG-ACTING STARCH NANOPARTICLE DRUG DELIVERY SYSTEM TO TREAT MULTIPLE MYELOMA

EHA Library, Sauli Vuoti, 325698

KNOCKOUT OF CD96 OR TIGIT USING CRISPR/CAS9 ENHANCES NK INDUCED CYTOTOXICITY AND CYTOKINE PRODUCTION IN THE PRESENCE OF CD155 EXPRESSING MYELOMA CELLS

EHA Library, John Daly, 325699

INDUCTION OF ELOTUZUMAB’S ADCC ACTIVITY BY TH1-LIKE GAMMA DELTA T CELLS TOWARDS OSTEOCLASTS AS WELL AS MYELOMA CELLS

EHA Library, Takeshi Harada, 325700

PROGRESSION AND DISSEMINATION OF EXPERIMENTAL MULTIPLE MYELOMA IS ASSOCIATED WITH LOSS OF INNATE AND ADAPTIVE IMMUNE-MEDIATED TUMOR CONTROL

EHA Library, Zoltán Kellermayer, 325701

SEA-BCMA, AN ENHANCED ANTIBODY FOR MULTIPLE MYELOMA, COMBINES EFFECTIVELY WITH MULTIPLE THERAPEUTIC MODALITIES

EHA Library, Heather Van Epps, 325702

MELFLUFEN RAPIDLY ACCUMULATES WITHIN TUMOR CELLS AND DISTRIBUTES AN ALKYLATING PAYLOAD TO THE NUCLEUS AND MITOCHONDRIA

EHA Library, Kenneth Flanagan, 325703

STUDY OF BONE MARROW MESENCHYMAL STEM CELLS REGULATING NK CELLS FUNCTION THROUGH TIGIT/ CD226 IN PATIENTS WITH MULTIPLE MYELOMA

EHA Library, Zhaoyun Liu, 325704

TUMOR ASSOCIATED MACROPHAGES INHIBIT CD8+T CELLS IMMUNE RESPONSES VIA PD-1/PD-L1 PATHWAY IN MULTIPLE MYELOMA

EHA Library, Zhaoyun Liu, 325705

COEXISTENCE OF MYELODYSPLASTIC SYNDROMES (MDS) AND MULTIPLE MYELOMA (MM)

EHA Library, Lenka Pavlistova, 325706

CLINICAL AND PHENOTYPIC FEATURES OF EXTRAMEDULLARY DISEASE IN MULTIPLE MYELOMA PATIENTS: THE POSSIBLE LACK OF CD38 EXPRESSION.

EHA Library, Fabrizio Accardi, 325707

INTEGRATIVE APPROACH TO FIND PREDICTIVE MARKERS OF RESPONSE TO DARATUMUMAB IN MULTIPLE MYELOMA

EHA Library, Camille Pochard, 325708

ALKBH5 PROMOTES THE PATHOGENESIS OF MULTIPLE MYELOMA THROUGH REGULATING LNCRNA SNHG15

EHA Library, Wu Qiuling, 325709

INTESTINAL MICROBIOTA AS A PROGNOSTIC BIOMARKER IN MULTIPLE MYELOMA

EHA Library, Alba Rodríguez-García, 325710

LNCRNA MSTRG.29039.1 PROMOTES PROLIFERATION BY SPONGING HSA-MIR-12119 VIA JAK2/STAT3 PATHWAY IN MULTIPLE MYELOMA

EHA Library, Zhaoyun Liu, 325711

DYSREGULATED EXOSOMAL MICRORNA EXPRESSION IN BONE MARROW MICROENVIRONMENT OF MULTIPLE MYELOMA, EXTRAMEDULLARY MULTIPLE MYELOMA AND PLASMA CELL LEUKEMIA

EHA Library, Jana Gregorová, 325712

LACK OF CD56 AS A POOR PROGNOSTIC MARKER IN PATIENTS WITH MULTIPLE MYELOMA

EHA Library, Andreas Epameinondas Koumpis, 325713

TRANSCRIPTOMIC ANALYSIS IDENTIFIED GENE CO-EXPRESSION AND CORRELATION WITH MULTIPLE MYELOMA PROGRESSION.

EHA Library, Olayinka Adebayo, 325714

THE ADIPONECTIN RECEPTOR AGONIST, ADIPORON, EXERTS ANTIPROLIFERATIVE AND PRO-APOPTOTIC EFFECTS THROUGH THE REGULATION OF ADIPORS/AMPK/ACC PATHWAY ON HUMAN MULTIPLE MYELOMA CELLS

EHA Library, Jing Zhang, 325715